摘要
目的探讨血清C肽、糖化血红蛋白检验在糖尿病诊断中的临床价值,为糖尿病检测提供科学可靠地依据。方法以该院2012年3月—2015年6月收治的160例糖尿病患者为研究对象,根据糖尿病类型分为糖尿病组(98例患有单纯2型糖尿病患者)和糖尿病肾病组(62例患有糖尿病肾病患者),另外选取同期健康体检者45名作为对照组。检测各组患者血清C肽、HbA1c、空腹血糖以及用餐后2h血糖等指标变化。结果糖尿病组和糖尿病肾病组患者血清C肽水平显著低于对照组,血清HbA1c、FBG、餐后2h血糖明显高于对照组(P<0.05);糖尿病肾病组患者的血清C肽水平显著低于对照组患者,血清HbA1c含量明显高于对照组(P<0.05);糖尿病组和糖尿病肾病组患者的FBG和餐后2h血糖含量差异无统计学意义(P>0.05);血清HbA1c含量与血清C肽呈负相关和FBG呈正相关关系(P<0.05)。结论糖尿病发生时患者血清C肽和HbA1c水平变化明显,可以作为诊断糖尿病,判定病情严重程度的重要参考指标。
Objective To investigate the clinical value of serum C peptide and glycosylated hemoglobin test in the diagnosis of diabetes,and provide a scientific basis for the diagnosis of diabetes.Methods 160 patients for Marth 2012 to June 2015 with diabetes were divided into diabetic group（98 patients with type 2 diabetes） and diabetic nephropathy group（62 patients with diabetic nephropathy）,and 45 cases of healthy physical examination were selected as control group,Serum C peptide,HbA1c,fasting blood glucose and 2H blood glucose were detected.Results Serum C level was significantly lower in the diabetic group and diabetic nephropathy group than in the control group,serum FBG,C and postprandial 2h blood glucose were significantly higher than those in the control group（P〈0.05）.Serum HbA1c level was significantly higher than that in control group（P〈0.05）,FBG and 2h in diabetic group and diabetic nephropathy group were not significantly different（P〈0.05）; serum C level was negatively correlated with serum FBG peptide（P〈0.05）.Conclusion Serum levels of C and HbA1c in patients with diabetes mellitus can be used as an important reference index for the diagnosis of diabetes mellitus.
出处
《糖尿病新世界》
2016年第5期111-113,共3页
Diabetes New World Magazine
关键词
糖尿病
血清C肽
糖化血红蛋白
诊断
Diabetes mellitus
Serum C peptide
Glycosylated hemoglobin
Diagnosis
